Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…oadjuvant FOLFIRINOX (folinic acid, 5-fluorouracil, irinotecan, oxaliplatin) chemotherapy for borderline resectable pancreatic adenocarcino…
…nt and reprocessing. The most expensive medicines returned were hydroxycarbamide (£22,276), cannabidiol (£19,545) and sapropterin (£6,783). The …
…d of care (initial prednisolone; Arm A) with the anti-TNF drug, adalimumab without glucocorticoids (Arm B).The primary outcome is glucocor…
… Due to therapeutic failure with rituximab, she was switched to anifrolumab. Twelve days after the first infusion, she developed a painful …
…nd plasma exchange was given without efficacy so treatment with obinutuzumab plus cyclophosphamide was initiated, with gradual neurological …
…eous, articular e serosae involvement, on baseline therapy with hydroxychloroquine 200 mg/day and prednisolone 10 mg/day due to recent flare with …
… a saline suppression test in 2025 confirmed PA. Treatment with spironolactone (25mg daily, later increased to 37.5mg) is ongoing, with partia…
…2% female; 96.0% Caucasian). At enrolment, 88.2% were receiving hydroxychloroquine (n=179). Overweight/obesity prevalence was 60.1%, and 83.3% had…
…s including haematology, ii) no increase in medication and iii) prednisolone dose <=5mg/day on at least 2 consecutive visits at least 6 mont…
…AS) and treated with antimalarials only, and were not receiving prednisolone. We assessed differential gene expression, interferon (IFN) sig…
…previa (PP) were recorded in the MB group, all treated with low LMWH prophylactic dose. Two MB and 5 non-MB patients experienced PE …
…d proteinuria (+18.1%).Conclusions Most patients withdrawn from prednisolone did not experience a LN flare. SLEDAI scores were higher in the…